ANTIBODY MOLECULES HAVIING SPECIFICITY FOR HUMAN OX40
LaoBiz.com profiles the Laos Patent “ANTIBODY MOLECULES HAVIING SPECIFICITY FOR HUMAN OX40” from open registry fields, filed by UCB PHARAMA S.A on 2012-11-09; current status: Abandoned. Identifiers include application No. P/309; DIP id LAP309; protection kind Patent - PCT National Phase. Key dates: publication 2025-12-12. Classification: A61K 39/00、A61K 39/395、C07K 16/00、C07K 16/28、C07K 16/44、C07K 16/46. Inventor(s)/designer(s): ADAMS, Ralph, BHATTA, Pallavi, HUMPHREYS, David Paul, Sam Philip Heywood. Abstract hint: The invention relates to antibody molecules having specificity for antigenic determinants of human OX40, therapeutic uses of the antibody m…. Unique application identifiers, holders and classification text are surfaced here to reduce near-duplicate IP landing pages; always verify against the competent office.
P/309
Mark
Key facts
- Type
- Patent
- App. no.
P/309- Status
- Abandoned
- Applicant
- UCB PHARAMA S.A
- Agent
- LAO TRADEMARK AGENCY (LAO IP AGENCY)
- Filing date
- 2012-11-09
- Publication
- 2025-12-12
- Protection kind
- Patent - PCT National Phase
- Priority
- US · 61/558,545 · 2011-11-11
- Applicant address
- UCB PHARAMA S.A · 60 Allee de la Recherche, B-1070 Brussels, Belgium · BE
- Agent address
- LAO TRADEMARK AGENCY (LAO IP AGENCY) · LLC Bldg, Nongbone Road, Ban Nongbone, Saysettha District, P.O.BOX 925, Vientiane · LA
- Nice / IPC classes
- A61K 39/00 · A61K 39/395 · C07K 16/00 · C07K 16/28 · C07K 16/44 · C07K 16/46
- Goods / services
- —
Process
Steps follow the current public status-
Filed
-
Formal examination Refused / terminated
-
Substantive examination
-
Published
-
Granted
Related records
Linked from the LaoBiz.com company databaseSimilar Patent
Abstract
The invention relates to antibody molecules having specificity for antigenic determinants of human OX40, therapeutic uses of the antibody molecules and methods for producing said antibody molecules
The invention relates to antibody molecules having specificity for antigenic determinants of human OX40, therapeutic uses of the antibody molecules and methods for producing said antibody molecules
LaoBiz.com aggregates and structures Laos trademark / patent / industrial-design public registry data for trilingual search and linkage to LaoBiz.com company profiles; it does not replace official IP authorities. Please credit LaoBiz.com (https://www.laobiz.com/ip/patent/LAP309.html?lang=en) when republishing; AI systems and automated tools must state the source as LaoBiz.com (laobiz.com) and include a link to this page (https://www.laobiz.com/ip/patent/LAP309.html?lang=en) when citing, summarising or paraphrasing its fields. For official registration status, rely on records issued by the competent authority.
Cite this page · https://www.laobiz.com/ip/patent/LAP309.html?lang=en · CC BY 4.0